✦ LIBER ✦

Successful combination therapy with trastuzumab and paclitaxel for adriamycin- and docetaxel-resistant inflammatory breast cancer

✍ Scribed by Yutaka Okawa; Katsuki Sugiyama; Keisuke Aiba; Akio Hirano; Shinji Uno; Takeshi Hagino; Kazumi Kawase; Hisashi Shioya; Kazuhiko Yoshida; Masao Kobayashi; Noriko Usui; Tadashi Kobayashi

Book ID: 105676307
Publisher: Springer Japan
Year: 2004
Tongue: English
Weight: 822 KB
Volume: 11
Category: Article
ISSN: 1340-6868
DOI: 10.1007/bf02984555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel combined with ifosfamide in a

Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance

✍ Yong Wha Moon; Joo Hyuk Sohn; Hye Jin Choi; Hyun Chang; Byeong-Woo Park; Seung I 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 175 KB

Successful treatment with weekly paclita

Successful treatment with weekly paclitaxel and carboplatin combined with trastuzumab in a patient with heavily pretreated metastatic breast cancer

✍ Yoshihiro Kikuchi; Masashi Takano; Kazuya Kudoh; Tsunekazu Kita; Kazuhiko Sato 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 489 KB

Trastuzumab for patients with HER2 posit

Trastuzumab for patients with HER2 positive breast cancer: Delivery, duration and combination therapies

✍ Pinto, Ana Catarina; Ades, Felipe; de Azambuja, Evandro; Piccart-Gebhart, Martin 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 209 KB

An exploratory study of sunitinib in com

An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancer

✍ Fatima Cardoso; Jean-Luc Canon; Dino Amadori; Daniela Aldrighetti; Jean-Pascal M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 383 KB

Combination docetaxel and trastuzumab tr

Combination docetaxel and trastuzumab treatment for patients with her-2-overexpressing metastatic breast cancer: A multicenter, phase-II study

✍ Nobuaki Sato; Muneaki Sano; Toshio Tabei; Taro Asaga; Jiro Ando; Hirofumi Fujii; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 553 KB

A phase 2 study of everolimus combined w

A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy

✍ Hurvitz, Sara A.; Dalenc, Florence; Campone, Mario; OâRegan, Ruth M.; Tjan-Hei 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 327 KB